Investcorp acquires Sanos Group

Investcorp acquires Sanos Group

TDT | Manama

The Daily Tribune - www.newsofbahrain.com

Investcorp, a provider and manager of alternative investment products, today announced that it has acquired Sanos Group (“Sanos”), a provider of specialized clinical trial services to the global pharmaceutical and biotechnology industry.

Based in Denmark, Sanos is a Contract Research Organization (CRO) providing value-added services to pharma, biotech and research organizations to help plan and conduct clinical trials, a critical part in the development of new drugs and treatments.

Sanos Group consists of a CRO specialized in osteoarthritis (OA) and a Site Management Organization (SMO) with a broader indication range focusing on lifestyle and age-related diseases.

The global CRO market is estimated to be approximately $50 billion and is growing at approximately 10% per annum, driven by increasing R&D spend to develop new drugs and treatments as well as a trend by pharma